TrialJournal of neurology2014

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

Ralf Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.